Centrient Pharmaceuticals
About Centrient Pharmaceuticals
Certifications
-
FDA -
GMP -
ISO
Categories
-
Country/Region:Netherlands
-
On CPHI since:2015
-
Certificates:3
-
Employees:1000 - 4999
Company types
Primary activities
Products from Centrient Pharmaceuticals (3)
-
Product API Product Portfolio
Penicillin G Penicillin G potassium Penicillin G procaine Penicillin G procaine sterile* Penicillin G benzathine sterile*
Beta-lactam Intermediates 6-amino-penicillanic acid (6-APA) 7-amino-deacetoxycephalosporanic acid (7-ADCA)
Semi-Synthetic Penicillins Amoxicillin trihydrate Ampicillin trihydr... -
Product FDF Product Portfolio
Finished Dosage Forms
Beta-lactam antibiotics
Amoxicillin Amoxicillin + Clavulanic acid
Statins
Atorvastatin Rosuvastatin
Anti-fungals
Caspofungin
Sterile injectables
Semi-Synthetic Penicillins (SSP)
Amoxicillin & Cloxacillin Ampicillin Sodium Amoxicill... -
Product 6-amino-penicillanic acid (6-APA)
6-amino-penicillanic acid (6-APA)
Centrient Pharmaceuticals Resources (2)
-
News Centrient Pharmaceuticals announces completion of acquisition of Astral SteriTech
Centrient Pharmaceuticals (“Centrient”), the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals, today announced the completion of the acquisition of Astral SteriTech Private Limited (“Astral SteriTech”).
With the addition of Astral SteriTech’s Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin sterile injectable finished dosage forms to Centrient’s product portfolio, the company can now further meet the needs of customers and reach more patients with its critical life-saving medicine.
-
Datasheet Overview Available MAs
Available Marketing Authorizations